Leitlinienreport des Addendums „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

Schlüsselwörter

Bulevirtid - Lebererkrankungen - Leberzirrhose - Hepatitis D - Ko-Infektionen - Therapie - HDV-Infektion - HDV

Publication History

Received: 05 September 2023

Accepted: 24 September 2023

Article published online:
11 December 2023

• Literatur

• 1 Cornberg M, Sandmann L, Protzer U. et al. S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11). Z Gastroenterol 2021; 59: 691-776
• 2 Fattovich G, Boscaro S, Noventa F. et al. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 1987; 155: 931-935
• 3 Fattovich G, Giustina G, Christensen E. et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000; 46: 420-426
• 4 Miao Z, Zhang S, Ou X. et al. Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection. J Infect Dis 2020; 221: 1677-1687
• 5 Stockdale AJ, Kreuels B, Henrion MYR. et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol 2020; 73: 523-532
• 6 Béguelin C, Moradpour D, Sahli R. et al. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. J Hepatol 2017; 66: 297-303
• 7 Kamal H, Westman G, Falconer K. et al. Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related Outcomes. Hepatology 2020; 72: 1177-1190
• 8 Alfaiate D, Clément S, Gomes D. et al. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. J Hepatol 2020; 73: 533-539
• 9 Kamal H, Fornes R, Simin J. et al. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies. J Viral Hepat 2021;
• 10 Le Gal F, Brichler S, Sahli R. et al. First international external quality assessment for hepatitis delta virus RNA quantification in plasma. Hepatology 2016; 64: 1483-1494
• 11 Bremer B, Anastasiou OE, Ciesek S. et al. Automated nucleic acid isolation methods for HDV viral load quantification can lead to viral load underestimation. Antivir Ther 2019; 24: 117-123